Y. Liu et al. / Tetrahedron Letters 54 (2013) 402–405
405
4. (a) Yadav, D. K.; Gautam, A. K.; Kureel, J.; Srivastava, K.; Sahai, M.; Singh, D.;
Chattopadhyay, N.; Maurya, R. Bioorg. Med. Chem. Lett. 2011, 21, 677; (b) Yeap,
G. Y.; Yama, W. S.; Dominiak, P.; Ito, M. M. J. Mol. Struct. 2010, 967, 25; (c)
McKie, J. A.; Bhagwat, S. S.; Brady, H.; Doubleday, M.; Gayo, L.; Hickman, M.;
Jalluri, R. K.; Khammungkhune, S.; Kois, A.; Mortensen, D.; Richard, N.;
Sapienza, J.; Shevlin, G.; Steinb, B.; Sutherlandb, M. Bioorg. Med. Chem. Lett.
2004, 14, 3407.
5. (a) Navarro, O.; Marion, N.; Oonishi, Y.; Kelly, R. A., III; Nolan, S. P. J. Org. Chem.
2006, 71, 685; (b) Landers, B.; Berini, C.; Wang, C.; Navarro, O. J. Org. Chem.
2011, 76, 1390; (c) Viciu, M. S.; Germaneau, R. F.; Nolan, S. P. Org. Lett. 2002, 4,
4053; (d) Navarro, O.; Marion, N.; Scott, N. M.; González, J.; Amoroso, D.; Bell,
A.; Nolan, S. P. Tetrahedron 2005, 61, 9716; (e) Cao, C.; Wang, L.; Cai, Z.; Zhang,
L.; Guo, J.; Pang, G.; Shi, Y. Eur. J. Org. Chem. 2011, 1570; (f) Moradi, W. A.;
Buchwald, S. L. J. Am. Chem. Soc. 2001, 123, 7996; (g) Fox, J. M.; Huang, X.;
Chieffi, A.; Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 1360; (h) Miao, T.; Wang,
G.-W. Chem. Commun. 2011, 47, 9501; (i) Zhang, J.; Yang, X.; Cui, X.; Wu, Y.
Tetrahedron 2011, 67, 8800; (j) Lin, L.; Li, Y.; Du, W.; Deng, W.-P. Tetrahedron
Lett. 2010, 51, 3571.
80 °C, which indicated that the reaction did proceed via the Truce
Smiles rearrangement (Scheme 3).
To explore the scope of the methodology, we employed
1-(5-chloro-2-hydroxyphenyl)ethanone and 1-(2-hydroxy-5-
methylphenyl)ethanone as substrates. The result was listed in
Table 3 and Figure 3. We are pleased to find the remarkable toler-
ance for the substrates to benzene and heterocyclic compound
with the yields ranging from 71% to 82%.
Conclusion
In conclusion, a variety of functionalized
a-arylated ketones
were systematically obtained in moderate to excellent yields via
the Truce Smiles rearrangement under mild conditions. This C–C
bond formation method for the construction of the a-arylated ke-
tones has wide applications in medicinal chemistry.
6. Jenkins, S. S. J. Am. Chem. Soc. 1933, 55, 2896.
7. Dolhem, E.; Barhdadi, R.; Folest, J. C.; Nédelec, J. Y.; Troupel, M. Tetrahedron
2001, 57, 525.
8. (a) Okuda, K.; Deguchi, H.; Kashino, S.; Hirota, T.; Sasaki, K. Chem. Pharm. Bull.
2010, 58, 685; (b) Okuda, K.; Yoshida, M.; Hirota, T.; Sasaki, K. Chem. Pharm.
Bull. 2010, 58, 363; (c) Snape, T. J. Synlett 2008, 2689; (d) Mitchell, L. H.;
Barvian, N. C. Tetrahedron Lett. 2004, 45, 5669; (e) Kitching, M. O.; Hurst, T. E.;
Snieckus, V. Angew. Chem., Int. Ed. 2012, 51, 1; (f) Tian, X.; Wang, L.; Xia, S.; Li,
Z.; Liu, X.; Yuan, Y.; Fang, L.; Zuo, H. Bioorg. Med. Chem. Lett. 2012, 22, 204; (g)
Guilarte, V.; Castroviejo, M. P.; García-García, P.; Fernández-Rodríguez, M. A.;
Sanz, R. J. Org. Chem. 2011, 76, 3416; (h) El Kaïm, L.; Grimaud, L.; Purumandla, S.
R. J. Org. Chem. 2011, 76, 4728; (i) González, J. P.; Edgar, M.; Elsegood, M. R. J.;
Weaver, G. W. Org. Biomol. Chem. 2011, 9, 2294; (j) Pudlo, M.; Allart-Simon, I.;
Tinant, B.; Gérard, S.; Sapi, J. Chem. Commun. 2012, 48, 2442.
9. (a) Liu, Y. L.; Chu, C. X.; Huang, A. P.; Zhan, C. J.; Ma, Y.; Ma, C. ACS Comb. Sci.
2011, 13, 547; (b) Liu, Y. L.; Ma, Y.; Zhan, C. J.; Huang, A. P.; Ma, C. Synlett 2012,
23, 255; (c) Huang, A. P.; Qiao, Z.; Zhang, X. H.; Yu, W.; Zheng, Q. Q.; Ma, Y.; Ma,
C. Tetrahedron 2012, 68, 906; (d) Huang, A. P.; Liu, F.; Zhan, C. J.; Liu, Y. L.; Ma, C.
Org. Biomol. Chem. 2011, 9, 7351.
10. A typical synthetic process and characterization data (NMR and MS): To a solution
of 1-(2-hydroxyphenyl)ethanone (150 mg, 1.1 mmol) in DMSO (10 mL) were
added 1,2-difluoro-4-nitrobenzene (150 mg, 0.92 mmol) and K2CO3 (380 mg,
2.76 mmol), then the mixture was stirred for 17 h at room temperature, and
then H2O (30 mL) was added and the mixture was extracted with EtOAc
(3 Â 25 mL). The combined organic layers were washed with sat. brine
(2 Â 20 mL), dried over MgSO4, filtered, and evaporated in vacuo. The crude
product was purified by column chromatography on silica gel (PE/EtOAc = 5:1)
to afford the desired product 3c as a yellow solid (222 mg, 88%). 1H NMR
(100 MHz, CDCl3) d 11.84 (s, 1H), 8.05–8.08 (dd, 1H, J = 1.92, 8.36 Hz), 7.99–
8.02 (dd, 1H, J = 2.2, 9.24 Hz), 7.85–7.88 (dd, 1H, J = 1.4, 8.04 Hz), 7.52–7.56 (m,
1H), 7.44–7.48 (m, 1H), 7.26 (s, 1H), 7.02–7.04 (dd, 1H, J = 0.6, 8.4 Hz). 6.96–
7.00 (m, 1H), 4.48 (s, 1H). 13C NMR (75 MHz, CDCl3) d 200.5, 162.7, 162.2,
158.9, 137.2, 132.5, 132.5, 129.7, 129.1, 128.9, 119.4, 119.3, 118.9, 118.7, 115.5,
111.2, 38.4. HRMS Calcd for C14H10FNO4, 275.0594. Found, 275.0667.
Acknowledgment
We are grateful to the National Science Foundation of China
(No. 21172131), IIFSDU (No. 2010TS052), and the State Key Labo-
ratory of Natural and Biomimetic Drugs of Peking University
(K20090205) for financial support of this research.
Supplementary data
Supplementary data (representative experimental procedures
and spectral data of compounds 3a–q are detailed.) associated with
References and notes
1. Tang, L. N.; Pang, Y. L.; Yan, Q.; Shi, L. Q.; Huang, J. H.; Du, Y. F.; Zhao, K. J. Org.
Chem. 2011, 76, 2744.
2. Chittimalla, S. K.; Chang, T.-C.; Liu, T.-C.; Hsieh, H. P.; Liao, C.-C. Tetrahedron
2008, 64, 2586.
3. (a) Xiang, H.; Zhao, W.; Xiao, H.; Qian, L.; Yao, Y.; Li, X.-B.; Liao, Q.-J. Bioorg. Med.
Chem. Lett. 2010, 18, 3036; (b) Kim, Y.-W.; Hackett, J. C.; Brueggemeier, R. W. J.
Med. Chem. 2004, 47, 4032; (c) Schuda, P. F.; Price, W. A. J. Org. Chem. 1972,
1987, 52; (d) Al-Maharik, N. I.; Kaltia, S. A. A.; Mutikainen, I.; Wähälä, K. J. Org.
Chem. 2000, 65, 2305.